Dr. Tarolli graduated from Syracuse University in 2007 and received his MD from SUNY Downstate College of Medicine in 2012. He completed his internship in internal medicine and residency in neurology at the University of Rochester Medical Center and graduated in 2016. Dr. Tarolli completed a fellowship in movement disorders and experimental therapeutics of neurological disease in 2018. He joined the faculty in 2018 and specializes in the care of individuals with Parkinson disease, atypical parkinsonian syndromes, and Huntington disease.

Beyond clinical work, Dr. Tarolli is a neurological educator and obtained a Masters of Science in Health Professions Education from the Warner School at the University of Rochester. He is the Director of the Mind, Brain, Behavior neuroscience course at the University of Rochester School of Medicine and Dentistry and Associate Program Director of the Adult Neurology Residency Program. He is also involved in clinical research focusing on novel technologies, practice-based research, and palliative care in individuals with Parkinson disease and other movement disorders.

Faculty Appointments

Associate Professor - Department of Neurology, Movement Disorders (SMD)

Associate Professor - Center for Health and Technology - Joint

Credentials

Residency & Fellowship

Fellowship, Movement Disorders, University of Rochester Medical Center. 2016 - 2018

Residency, Neurology, University of Rochester Medical Center. 2012 - 2016

Education

MD | University of Rochester. 2019

MD | SUNY Downstate Health Sciences University - College of Medicine. 2012

Awards

Herbert W. Mapstone Prize for Excellence in Second Year Teaching.

American Academy of Neurology Emerging Leaders Program.

Publications

Journal Articles

A real-world study of wearable sensors in Parkinson's disease.

Adams JL, Dinesh K, Snyder CW, Xiong M, Tarolli CG, Sharma S, Dorsey ER, Sharma G

NPJ Parkinson's disease.. 2021 November 297 (1):106. Epub 11/29/2021.

GEORGE ®: A Pilot Study of a Smartphone Application for Huntington's Disease.

Waddell EM, Dinesh K, Spear KL, Elson MJ, Wagner E, Curtis MJ, Mitten DJ, Tarolli CG, Sharma G, Ray Dorsey E, Adams JL

Journal of Huntington's disease.. 2021 March 30 Epub 03/30/2021.

Palliative Care in Movement Disorders: an Evolving Field.

Macchi ZA, Tarolli CG, Kluger BM

Current neurology and neuroscience reports.. 2021 January 2821 (3):5. Epub 01/28/2021.

Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).

Schneider RB, Omberg L, Macklin EA, Daeschler M, Bataille L, Anthwal S, Myers TL, Baloga E, Duquette S, Snyder P, Amodeo K, Tarolli CG, Adams JL, Callahan KF, Gottesman J, Kopil CM, Lungu C, Ascherio A, Beck JC, Biglan K, Espay AJ, Tanner C, Oakes D, Shoulson I, Novak D, Kayson E, Ray Dorsey E, Mangravite L, Schwarzschild MA, Simuni T,

Annals of clinical and translational neurology.. 2020 December 22 Epub 12/22/2020.

A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability.

Schneider RB, Auinger P, Tarolli CG, Iourinets J, Gil-Díaz MC, Richard IH

Parkinsonism & related disorders.. 2020 October 1381 :69-74. Epub 10/13/2020.

Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson's Disease.

Tarolli CG, Andrzejewski K, Zimmerman GA, Bull M, Goldenthal S, Auinger P, O'Brien M, Dorsey ER, Biglan K, Simuni T

Journal of Parkinson's disease.. 2020 September 4 Epub 09/04/2020.

Remote Administration of the MDS-UPDRS in the Time of COVID-19 and Beyond.

Schneider RB, Myers TL, Tarolli CG, Amodeo K, Adams JL, Jensen-Roberts S, Dorsey ER

Journal of Parkinson's disease.. 2020 July 15 Epub 07/15/2020.

Deep Phenotyping of Parkinson's Disease.

Dorsey ER, Omberg L, Waddell E, Adams JL, Adams R, Ali MR, Amodeo K, Arky A, Augustine EF, Dinesh K, Hoque ME, Glidden AM, Jensen-Roberts S, Kabelac Z, Katabi D, Kieburtz K, Kinel DR, Little MA, Lizarraga KJ, Myers T, Riggare S, Rosero SZ, Saria S, Schifitto G, Schneider RB, Sharma G, Shoulson I, Stevenson EA, Tarolli CG, Luo J, McDermott MP

Journal of Parkinson's disease.. 2020 May 22 Epub 05/22/2020.

Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.

Annals of internal medicine.. 2020 May 5172 (9):591-598. Epub 03/31/2020.

Author response: Symptom burden among individuals with Parkinson disease: A national survey.

Tarolli CG

Neurology. Clinical practice.. 2020 April 10 (2):90. Epub 1900 01 01.

Palliative care and Parkinson's disease: outpatient needs and models of care over the disease trajectory.

Tarolli CG, Holloway RG

Annals of palliative medicine.. 2020 February 9 (Suppl 1):S44-S51. Epub 12/13/2019.

Quality measures in Parkinson disease: What do the outcomes show?

Tarolli CG, Barbano R

Neurology. Clinical practice.. 2020 February 10 (1):5-6. Epub 10/30/2019.

Video research visits for atypical parkinsonian syndromes among Fox Trial Finder participants.

Tarolli CG, Zimmerman GA, Goldenthal S, Feldman B, Berk S, Siddiqi B, Kopil CM, Chowdhury S, Biglan KM, Dorsey ER, Adams JL

Neurology. Clinical practice.. 2020 February 10 (1):7-14. Epub 1900 01 01.

Symptom burden among individuals with Parkinson disease: A national survey.

Tarolli CG, Zimmerman GA, Auinger P, McIntosh S, Horowitz RK, Kluger BM, Dorsey ER, Holloway RG

Neurology. Clinical practice.. 2020 February 10 (1):65-72. Epub 11/18/2019.

A Longitudinal Wearable Sensor Study in Huntington's Disease.

Dinesh K, Snyder CW, Xiong M, Tarolli CG, Sharma S, Dorsey ER, Sharma G, Adams JL

Journal of Huntington's disease.. 2019 December 18 Epub 12/18/2019.

Palliative care and advance care planning in Parkinson disease.

Tuck KK, Tarolli CG

Neurology.. 2019 May 2892 (22):1039-1040. Epub 04/26/2019.

Passive Monitoring at Home: A Pilot Study in Parkinson Disease.

Kabelac Z, Tarolli CG, Snyder C, Feldman B, Glidden A, Hsu CY, Hristov R, Dorsey ER, Katabi D

Digital biomarkers.. 2019 3 (1):22-30. Epub 04/30/2019.

Managing Neurophobia: How Can We Meet the Current and Future Needs of Our Students?

Tarolli CG, Józefowicz RF

Seminars in neurology.. 2018 August 38 (4):407-412. Epub 08/20/2018.

Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score.

Zhan A, Mohan S, Tarolli C, Schneider RB, Adams JL, Sharma S, Elson MJ, Spear KL, Glidden AM, Little MA, Terzis A, Dorsey ER, Saria S

JAMA neurology.. 2018 July 175 (7):876-880. Epub 1900 01 01.

Multiple wearable sensors in Parkinson and Huntington disease individuals: a pilot study in clinic and at home

Adams JL, Dinesh K, Xiong M, Tarolli CG, Sharma S, Sheth N, Aranyosi AJ, Zhu W, Goldenthal S, Biglan KM, Dorsey ER, Sharma G.

Digital Biomarkers. 2017; 1: 52-63.

Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature.

Tarolli CG, Chesire AM, Biglan KM

Tremor and other hyperkinetic movements.. 2017 7 :454. Epub 04/11/2017.

Next Generation House Call.

Adams JL, Tarolli CG, Dorsey ER

Cerebrum : the Dana forum on brain science.. 2017 2017 Epub 01/01/2017.

Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home.

Adams JL, Dinesh K, Xiong M, Tarolli CG, Sharma S, Sheth N, Aranyosi AJ, Zhu W, Goldenthal S, Biglan KM, Dorsey ER, Sharma G

Digital biomarkers.. 2017 1 (1):52-63. Epub 08/17/2017.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.